Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Achiko
Achiko
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Achiko
Stock Price
$0
2024-10-29
Market Capitalization
$377.4 K
2024-10-29
Revenue
$63 K
FY, 2021
Achiko Summary
Company Summary
Overview
Achiko is a provider of disruptive diagnostic solutions. It offers AptameX, a rapid test that uses DNA aptamers to detect SARS-CoV-2; digital health passports, etc.
Type
Public
Status
Active
Founded
2018
Website
https://www.achiko.com
Cybersecurity rating
Sectors
Healthcare
medical diagnostics
Homepage
Linkedin
instagram
facebook
youtube
twitter
Table of Contents
Financials
Competitors
Achiko Financials
Summary Financials
Gross profit (H1, 2022)
$11.0K
Net income (H1, 2022)
($2.5M)
Cash (H1, 2022)
$54.0K
EBIT (H1, 2022)
($2.0M)
Enterprise value
$4.5M
Competitors and Similar Companies
Thyrocare
Healthcare - Public
Ampath Laboratories
Healthcare - Private
Eka Hospital
Healthcare - Private
Chughtai Lab
Healthcare - Private
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top